Core Viewpoint - The market anticipates Eagle Materials (EXP) will report a year-over-year increase in earnings driven by higher revenues for the quarter ending March 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Eagle Materials is expected to report quarterly earnings of $2.34 per share, reflecting a year-over-year increase of 4.5%, with revenues projected at $477.78 million, a slight increase of 0.2% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 3.3% over the last 30 days, indicating a collective reassessment by analysts regarding the company's earnings outlook [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Eagle Materials is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -3.98%, suggesting a bearish sentiment among analysts [10][11]. Historical Performance - In the last reported quarter, Eagle Materials was expected to post earnings of $4 per share but only achieved $3.59, resulting in a surprise of -10.25%. Over the last four quarters, the company has only beaten consensus EPS estimates once [12][13]. Conclusion - Eagle Materials does not appear to be a strong candidate for an earnings beat, and investors should consider other factors when making decisions regarding the stock ahead of its earnings release [16].

The market expects Palo Alto Networks (PANW) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 20, 2025, might help the stock move higher if these key numbers ...

ViaSat (VSAT) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock may move l ...

The market expects Keysight (KEYS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 20, 2025, might help the stock move higher if these key numbers are better ...

分组1 - Simon Property (SPG) reported quarterly funds from operations (FFO) of $2.95 per share, exceeding the Zacks Consensus Estimate of $2.91 per share, but down from $3.56 per share a year ago, indicating an FFO surprise of 1.37% [1] - The company posted revenues of $1.47 billion for the quarter ended March 2025, missing the Zacks Consensus Estimate by 0.67%, compared to $1.44 billion in the same quarter last year [2] - Over the last four quarters, Simon Property has surpassed consensus FFO estimates two times and topped consensus revenue estimates three times [2] 分组2 - The stock has underperformed the market, losing about 5.2% since the beginning of the year, while the S&P 500 declined by 3.8% [3] - The current consensus FFO estimate for the coming quarter is $3.04 on revenues of $1.5 billion, and for the current fiscal year, it is $12.54 on revenues of $6.12 billion [7] - The Zacks Industry Rank for REIT and Equity Trust - Retail is currently in the top 28% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

Core Insights - Dianthus Therapeutics, Inc. reported a quarterly loss of $0.82 per share, which was better than the Zacks Consensus Estimate of a loss of $0.86, but worse than the loss of $0.54 per share from the previous year, indicating a 51.85% increase in loss year-over-year [1] - The company achieved revenues of $1.16 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.13% and showing a 33.33% increase from $0.87 million in the same quarter last year [2] - The stock has underperformed the market, losing approximately 10.1% since the beginning of the year compared to the S&P 500's decline of 3.8% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.93 on revenues of $1.36 million, while for the current fiscal year, the estimate is -$3.38 on revenues of $5.17 million [7] - The estimate revisions trend for Dianthus Therapeutics is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] Industry Context - The Medical - Biomedical and Genetics industry, to which Dianthus Therapeutics belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

The market expects ICL Group (ICL) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 19, 2025, might help the stock move higher if these key numbers are better ...

Oportun Financial Corporation (OPRT) reported $235.9 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 5.8%. EPS of $0.40 for the same period compares to $0.09 a year ago.The reported revenue represents a surprise of +2.98% over the Zacks Consensus Estimate of $229.08 million. With the consensus EPS estimate being $0.09, the EPS surprise was +344.44%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they co ...

Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when Flowers Foods (FLO) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May ...

Algonquin Power & Utilities (AQN) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 55.56%. A quarter ago, it was expected that this utility operator would post earnings of $0.08 per share when it actually produced earnings of $0.06, delivering a surprise of -25%.Over the last four quar ...